Comparing Remicade vs Ustekinumab
| Remicade (infliximab) | Ustekinumab |
|
|---|
| Remicade (infliximab) | Ustekinumab |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Ankylosing Spondylitis, Ulcerative Colitis, Crohn's Disease, Crohn's Disease - Active, Inflammatory Bowel Disease, Plaque Psoriasis, Psoriasis, Psoriatic Arthritis, Rheumatoid... View more |
Prescription only
Prescribed for Crohn's Disease, Crohn's Disease - Active, Psoriasis, Plaque Psoriasis, Psoriatic Arthritis, Ulcerative Colitis, Ulcerative Colitis - Active. Ustekinumab may also be used for purposes... View more |
Related suggestions Ulcerative Colitis
|
|||||||||||||||
| More about Remicade (infliximab) | More about Ustekinumab | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Remicade has an average rating of 7.0 out of 10 from a total of 214 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 20% reported a negative effect. |
Ustekinumab has an average rating of 7.5 out of 10 from a total of 270 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 16% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Remicade side effects |
View all Ustekinumab side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
Lower cost generic |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Remicade prices |
View all Ustekinumab prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other infliximab brands include: Avsola, Inflectra, Ixifi, Renflexis, Zymfentra | Imuldosa, Otulfi, Pyzchiva, Selarsdi, Starjemza, Stelara, Steqeyma, Wezlana, Yesintek View more | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
228 hours |
1291.2 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 572 drugs are known to interact with Remicade:
|
A total of 542 drugs are known to interact with Ustekinumab:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
August 24, 1998 |
September 25, 2009 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.